Top Markets
#1 QuantixAI QuantixAI +63.61%
#2 Versatize Coin Versatize Coin +40.00%
#3 GEKKO GEKKO +36.52%
#4 Pons Pons +30.26%
#5 UnifAI Network UnifAI Network +30.11%
#6 MowCat MowCat +29.89%
#7 Prom Prom +28.67%
#8 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +26.23%
#9 MarsCoin MarsCoin +25.18%
#10 Kinesis Silver Kinesis Silver +23.42%
Coin of the day
QuantixAI QuantixAI
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Vaxart, Inc. Vaxart, Inc.

Vaxart, Inc.

VXRT
Kedudukan dalam Saham #20724
Vaxart, Inc. operates as a biotechnology firm currently in the clinical... Vaxart, Inc. operates as a biotechnology firm currently in the clinical development phase, concentrating its efforts on identifying and advancing novel oral recombinant protein vaccines. The company leverages its unique proprietary platform for delivering these oral vaccine solutions. Its diverse pipeline showcases several promising candidates: An oral tablet vaccine targeting norovirus, which is presently undergoing Phase Ib clinical assessment for both GI.1 and GII.4 strains. A seasonal influenza vaccine, now in Phase II clinical studies, designed to address H1 influenza infections. A vaccine candidate against respiratory syncytial virus (RSV). A coronavirus vaccine, also advancing through Phase II clinical trials for SARS-CoV-2. Beyond infectious diseases, Vaxart is also engaged in formulating therapeutic vaccines aimed at treating cervical cancer and dysplasia associated with human papillomavirus. The company's main operations are situated in South San Francisco, California.
Harga Saham
$0.5106
Modal Pasaran
$123.59M
Perubahan (1 hari)
-1.81%
Perubahan (1 tahun)
45.89%
Negara
US
Perdagangan Vaxart, Inc. (VXRT)

Kategori

Healthcare
Hasil untuk Vaxart, Inc. (VXRT)
Hasil pada Aug 2026 TTM: 0
Menurut laporan kewangan terkini daripada Vaxart, Inc., hasil semasa syarikat (TTM) ialah 0. Pada tahun 2026, syarikat memperoleh hasil sebanyak 0 sama dengan hasil pada tahun 2026 iaitu 0. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Vaxart, Inc. dari 2026 hingga 2026
Hasil pada akhir setiap tahun
Tahun Hasil Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil untuk syarikat atau pesaing serupa
Syarikat Hasil Perbezaan Hasil Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH